V015-7629 Screening compound: N-(6-{4-[2-(4-chlorophenoxy)acetyl]-1,4-diazepan-1-yl}pyridin-3-yl)-3,5-difluorobenzamide

V015-7629 Screening compound: N-(6-{4-[2-(4-chlorophenoxy)acetyl]-1,4-diazepan-1-yl}pyridin-3-yl)-3,5-difluorobenzamide
V015-7629 Screening compound: N-(6-{4-[2-(4-chlorophenoxy)acetyl]-1,4-diazepan-1-yl}pyridin-3-yl)-3,5-difluorobenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-7629
N-(6-{4-[2-(4-chlorophenoxy)acetyl]-1,4-diazepan-1-yl}pyridin-3-yl)-3,5-difluorobenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-7629

Molecular Formula

C25H23ClF2N4O3 (C25 H23 ClF2 N4 O3)

Compound Name

N-(6-{4-[2-(4-chlorophenoxy)acetyl]-1,4-diazepan-1-yl}pyridin-3-yl)-3,5-difluorobenzamide

IUPAC name

N-(6-{4-[2-(4-chlorophenoxy)acetyl]-14-diazepan-1-yl}pyridin-3-yl)-35-difluorobenzamide

SMILES

O=C(COc(cc1)ccc1Cl)N(CCC1)CCN1c(cc1)ncc1NC(c1cc(F)cc(F)c1)=O

InChI

InChI=1S/C25H23ClF2N4O3/c26-18-2-5-22(6-3-18)35-16-24(33)32-9-1-8-31(10-11-32)23-7-4-21(15-29-23)30-25(34)17-12-19(27)14-20(28)13-17/h2-7,12-15H,1,8-11,16H2,(H,30,34)

InChI Key

FYYMBZROMYVEIE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19911593

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

500.93

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.851

Distribution Coefficient, logD

4.835

Water Solubility, LogSw

-4.99

Polar Surface Area

59.142

Acid Dissociation Constant (pKa)

8.82

Base Dissociation Constant (pKb)

8.05

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

V015-7629 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V015-7629 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-7629?
Check Price and Availability of V015-7629, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-7629 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-7629
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-7629
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-7629 available by request